PHARMACY

Genentech has named Alexander Hardy its CEO effective March 1, succeeding Bill Anderson.

NACDS is making the case that DIR fee reform is necessary in its comments to the Centers for Medicare and Medicaid Services, which recently issued a proposed rule focused on reducing patient out-of-pocket costs.

BD's second-generation BD Nano pen needle is designed to help people better manage their diabetes, the company said.

As part of its long-term capital management strategy, Aetna has entered into a four-year reinsurance agreement with Vitality Re X.

Amerigen’s generic of Shire’s extended-release ADHD drug will be available in 5-, 10-, 15-, 20-, 25- and 30-mg dosage strengths.

Dr. Reddy's is offering generic Diprivan (propofol) injectable emulsion, which had a market value of roughly $310 million for the year ended November 2018, according to IQVIA data.

Lannett is launching generic Syprine and Comtan, which had a market value of $140 million, and $23 million, respectively.

Meghann Chilcott, formerly of OrderInsite, is joining Benzer Pharmacy as its chief technology and marketing officer.